Heathbridge Capital Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-29,110
| Closed | -$3.01M | – | 31 |
|
|
2023
Q3 | $3.01M | Sell |
29,110
-300
| -1% | -$31K | 1.38% | 19 |
|
|
2023
Q2 | $3.57M | Sell |
29,410
-1,175
| -4% | -$143K | 1.56% | 19 |
|
|
2023
Q1 | $4.7M | Sell |
30,585
-1,850
| -6% | -$284K | 1.98% | 18 |
|
|
2022
Q4 | $5.83M | Sell |
32,435
-17,650
| -35% | -$3.17M | 2.24% | 19 |
|
|
2022
Q3 | $5.92M | Sell |
50,085
-215
| -0.4% | -$25.4K | 2.68% | 15 |
|
|
2022
Q2 | $7.19M | Sell |
50,300
-230
| -0.5% | -$32.9K | 2.96% | 14 |
|
|
2022
Q1 | $8.7M | Sell |
50,530
-23,750
| -32% | -$4.09M | 2.77% | 15 |
|
|
2021
Q4 | $18.9M | Buy |
74,280
+5,905
| +9% | +$1.5M | 5.4% | 8 |
|
|
2021
Q3 | $26.3M | Sell |
68,375
-52,425
| -43% | -$20.2M | 7.9% | 7 |
|
|
2021
Q2 | $28.4M | Sell |
120,800
-23,550
| -16% | -$5.53M | 7.62% | 9 |
|
|
2021
Q1 | $18.9M | Buy |
+144,350
| New | +$18.9M | 5.19% | 8 |
|